Focus: AirLife is a publicly-traded biotechnology company specializing in respiratory and anesthesia devices, operating at a mid-sized scale (51-200 employees) from Grand Rapids, Michigan.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Growing — net +6 jobs in 30d
27 jobs added vs 21 removed. Steady team buildout.
AirLife offers commercial and operational stability in respiratory devices, but limited R&D careers and ongoing strategic realignment pose execution risk for growth-minded pharma professionals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AirLife
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from AirLife's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications